AVTX
Avalo Therapeutics Inc.
$13.67
-$0.28(-2.01%)
58
Overall
80
Value
63
Tech
31
Quality
Market Cap
$155.59M
Volume
273.88K
52W Range
$3.39 - $16.00
Target Price
$33.67
Key Metrics Overview
| Market Cap | $155.59M | P/E Ratio | N/A |
| 52W High | $16.00 | 52W Low | $3.39 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 91.8% | 52W Position | 81.5% |
| Overall Score | 58 | Value Score | 80 |
| Quality Score | 31 | Technical Score | 63 |
Growth Analysis
| EPS Current Est | $-5.8 | EPS Next Est | $-5.29 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVTX | $13.67 | -2.0% | 273.88K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |